9 completed, 1 unknown. 10 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 9, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Cefixime: new trials by email Literature Review of Cefixime trials Research Report on Cefixime
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women Cefixime, Benzathine penicillin 2.4 million units - Syphilis Female | Phase 1 / Phase 2 | Unknown | World Health Organization | 180 | 2019-11-22 | 2020-02-05 |
| Experimental Human Infection With Neisseria Gonorrhoeae Cefixime, Ceftriaxone, Ciprofloxacin - Gonococcal Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 27 | 2017-04-23 | 2021-03-23 |
| Cefixime / Azithromycin pK Study Azithromycin, Cefixime - Gonorrhoea | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2016-04-28 | 2017-09-15 |
| A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors Eribulin, Irinotecan, Cefixime - Relapsed Solid Tumors, Refractory Solid Tumors | Phase 1 | Completed | University of Colorado, Denver | 2 | 2015-10-21 | 2022-02-15 |
| The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study Cefixime - Gonorrhoea | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 25 | 2013-12-01 | 2019-01-17 |
| A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors Bevacizumab, Temozolomide, Vincristine - Solid Tumor | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 13 | 2008-10-01 | 2021-02-10 |
| Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma Irinotecan and Bortezomib - Neuroblastoma | Phase 1 | Completed | University of Michigan Rogel Cancer Center | 18 | 2008-04-01 | 2017-07-06 |
| N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma cefixime, irinotecan hydrochloride, temozolomide - Diarrhea, Drug/Agent Toxicity by Tissue/Organ | Phase 1 | Completed | New Approaches to Neuroblastoma Therapy Consortium | 30 | 2004-05-01 | 2026-04-14 |
| Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors Irinotecan, ZD1839, Vincristine, Cefixime, Cefpodoxime. - Solid Tumors | Phase 1 | Completed | St. Jude Children's Research Hospital | 34 | 2003-05-01 | 2017-04-26 |
| VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy salmonella VNP20009, cefixime, ceftriaxone sodium - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Vion Pharmaceuticals | 1999-08-01 | 2013-07-18 |
Gonorrhea (3) · Neuroblastoma (2) · Diarrhea (1) · Disease Susceptibility (1) · Drug-Related Side Effects and Adverse Reactions (1) · Sexually Transmitted Diseases (1) · Syphilis (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Children's Hospital Medical Center, Cincinnati (1) · New Approaches to Neuroblastoma Therapy Consortium (1) · St. Jude Children's Research Hospital (1) · University of Colorado, Denver (1) · University of Michigan Rogel Cancer Center (1) · Vion Pharmaceuticals (1) · World Health Organization (1)
United States (9) · Brazil (1)
Brian Turpin, D.O. (1) · Carrye Cost, MD (1) · Edna O Kara, MD (1) · Katherine K. Matthay, MD (1) · Lars M. Wagner, MD (1) · Mario Sznol, MD (1) · Melanie M Taylor, MD (1) · Nathalie JN Broutet, MD (1) · Rajen Mody, MD (1) · Tom Badgett, MD (1) · Wayne Furman, M.D. (1)
PMID 19171709, PMID 29624558, PMID 32522244, PMID 33640982, PMID 37425726, PMID 39321205
P01CA081403 (1)